New Ultrasound System Facilitates Catheter and IV Placement
Offering a variety of integrated visualization tools, the SiteRite 9 Ultrasound System reportedly enables the insertion of vascular access devices regardless of user experience level.
For clinicians placing central venous catheters, peripherally inserted central catheters (PICCs) and IV lines, BD has launched the SiteRite™ 9 Ultrasound System.
In addition to a 15.6-inch touch screen with enhanced image quality, the SiteRite 9 Ultrasound System enables real-time needle monitoring with the Cue™ Needle Tracking System and guided catheter tip navigation with the Sherlock 3CG+™ Tip Confirmation System, according to BD.
The company added that the system also facilitates appropriate catheter selection with a combination of automated vessel assessment tools and vessel measurement capability.
"Our latest innovation in ultrasound technology is designed to make vascular access care delivery easier and more efficient for clinicians — whether they've been on the job for years or are new to the field," said Eric Borin, the worldwide president of Medication Delivery Solutions at BD. " … We've developed a best-in-class solution to aid in insertion success on the first attempt and reduce the need for repeated needlesticks to deliver a better care experience for everyone involved."
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
